Collaboration Agreements (335)

Browse by Industry

Recent Contracts

License and Collaboration Agreement, dated as of November 15, 2017, as amended, by and between Regeneron Pharmaceuticals, Inc. and the Registrant (Decibel Therapeutics, Inc., Filed With SEC on January 22, 2021)
Amendment No. 3, dated December 9, 2020, to the Amended and Restated Sponsored Research, Collaboration and License Agreement by and between the Registrant and the Trustees of the... (Passage BIO, Inc., Filed With SEC on January 19, 2021)
Amendment No. 2, dated November 2, 2020, to the Amended and Restated Sponsored Research, Collaboration and License Agreement by and between the Registrant and the Trustees of the... (Passage BIO, Inc., Filed With SEC on January 19, 2021)
Amendment #1, dated January 13, 2021, to the License and Collaboration Agreement, dated December 2, 2019, by and between Xenon Pharmaceuticals Inc. and Neurocrine Biosciences, Inc (Xenon Pharmaceuticals Inc., Filed With SEC on January 14, 2021)
Amendment No. 1 to the Collaboration and License Agreement between Nanomerics Ltd. and Virpax Pharmaceuticals, Inc., dated as of December 31, 2020 (Virpax Pharmaceuticals, Inc., Filed With SEC on January 8, 2021)
Amendment 2 to the Collaboration Agreement between Certainty Therapeutics, Inc. and H. Lee Moffitt Cancer Center and Research Institute, Inc. (.) (Certain information has been... (Anixa Biosciences Inc, Filed With SEC on January 7, 2021)
Amendement to Collaboration Agreement between the Company and OntoChem GmbH (Anixa Biosciences Inc, Filed With SEC on January 7, 2021)
Collaboration Agreement, dated November 28, 2018, by and between Adimab, LLC and Cullinan Management, Inc (Cullinan Oncology, LLC, Filed With SEC on December 18, 2020)
License and Collaboration Agreement, dated February 4, 2019, by and between Taiho Pharmaceutical, Co., Ltd. and Cullinan Pearl Corp (Cullinan Oncology, LLC, Filed With SEC on December 18, 2020)
Collaboration Agreement, Notis Global, Inc. January 24, 2020 (GridIron BioNutrients, Inc., Filed With SEC on December 15, 2020)